A Phase 1 Study of BLKR201 in Healthy Adult Participants
Eligible age
18–55 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to learn if BLKR201 is safe in healthy adults. Researchers will also learn how the body absorbs and processes BLKR201 and how food may affect it. The main questions this study aims to answer are: * Is BLKR201 safe and well tolerated when taken as a single dose or for several days in a row? * How does BLKR201 move through and leave the body? * Does taking BLKR201 with food change how the body absorbs it? Researchers will compare BLKR201 to a placebo (a look-alike tablet that contains no drug) in most parts of the study to see how the drug affects participants. Participants will: * Take BLKR201 or a placebo by mouth * Stay at a clinical research unit for several days during dosing * Give blood and urine samples * Have heart tests, vital signs, and lab tests * Report any side effects In one part of the study, a small group of participants will receive BLKR201 only (no placebo). These participants will also have a sample of spinal fluid collected to measure how much BLKR201 reaches the fluid around the brain and spinal cord.
Sponsor: Formation Bio, Inc.
You may qualify if…
- ✓ Are a healthy man or woman 18 to 55 years old
- ✓ Weigh at least 50 kilograms (110 pounds)
- ✓ Have a body mass index (BMI) between 18 and 30 kg/m2 (inclusive)
- ✓ Are willing to stay at the research unit for the required study visits
- ✓ Are willing to follow study rules about diet, alcohol, tobacco, and medications
- ✓ Are able to understand and sign the informed consent form
- ✓ Women who can become pregnant must:
- ✓ Have a negative pregnancy test before starting
You may not qualify if…
- ✕ Have any significant medical condition involving the heart, lungs, liver, kidneys, stomach, intestines, brain, blood, or immune system
- ✕ Have abnormal laboratory test results at screening that the study doctor considers important
- ✕ Have a history of heart rhythm problems or abnormal electrocardiogram (ECG) results
- ✕ Have high blood pressure at screening
- ✕ Have had a serious infection within the past 6 months
- ✕ Test positive for HIV, hepatitis B, hepatitis C, or tuberculosis, or show evidence of hepatitis B infection (positive hepatitis B surface antigen or hepatitis B core antibody). Note: participants with hepatitis B immunity from vaccination alone may still be eligible.
- ✕ Have a history of cancer in the past 5 years (with limited exceptions for certain treated skin cancers)
- ✕ Have a history of serious stomach problems such as ulcers, stomach surgery, or stomach bleeding
Where it's recruiting
Lincoln
Source: ClinicalTrials.gov · NCT07501039 · last updated 2026-09-02